000 | 01213 a2200349 4500 | ||
---|---|---|---|
005 | 20250517221736.0 | ||
264 | 0 | _c20180720 | |
008 | 201807s 0 0 eng d | ||
022 | _a1347-5223 | ||
024 | 7 |
_a10.1248/cpb.c17-00966 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiang, Ting-Ting | |
245 | 0 | 0 |
_aModeling Analysis of Potential Target of Dolastatin 16 by Computational Virtual Screening. _h[electronic resource] |
260 |
_bChemical & pharmaceutical bulletin _c2018 |
||
300 |
_a602-607 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aDepsipeptides _xchemistry |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 | _aMolecular Conformation |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 |
_aTacrolimus _xchemistry |
650 | 0 | 4 |
_aTacrolimus Binding Proteins _xantagonists & inhibitors |
700 | 1 | _aZhao, Qi | |
700 | 1 | _aHe, Shan | |
700 | 1 | _aMu, Fang-Zhou | |
700 | 1 | _aDeng, Wei | |
700 | 1 | _aHan, Bing-Nan | |
773 | 0 |
_tChemical & pharmaceutical bulletin _gvol. 66 _gno. 6 _gp. 602-607 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1248/cpb.c17-00966 _zAvailable from publisher's website |
999 |
_c28491645 _d28491645 |